EMERALD MUTUAL FUND ADVISERS TRUST

Mutual Fund

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 1352895 Leola, PA

Position in KALV

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$16,219,989

+$2,404,294 QoQ

Shares Held

805,762

-5.8% QoQ

Ownership

1.51%

of shares outstanding

% of Portfolio

0.82%

of 13F equity value

Holder Rank

#25

of 182 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EMERALD MUTUAL FUND ADVISERS TRUST holds $276,373,005 across 22 Biotechnology names. KALV ranks #7 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COGT	Cogent Biosciences, Inc.	1,028,832	$39,599,743
2	TVTX	Travere Therapeutics, Inc.	945,033	$28,076,930
3	BBIO	BridgeBio Pharma, Inc.	320,211	$23,778,868
4	MIRM	Mirum Pharmaceuticals, Inc.	250,399	$23,131,859
5	SYRE	Spyre Therapeutics, Inc.	408,113	$20,585,219
6	NKTR	Nektar Therapeutics	256,106	$18,426,826
7	KALV	KalVista Pharmaceuticals, Inc. This page	805,762	$16,219,989
8	TRVI	Trevi Therapeutics, Inc.	1,262,492	$15,061,529

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,219,989	805,762	-5.8%	Shares	Sole	2026-05-04
2025-12-31	$13,815,695	855,461	-6.8%	Shares	Sole	2026-02-09
2025-09-30	$11,180,935	917,975	+19.4%	Shares	Sole	2025-10-30
2025-06-30	$8,693,228	768,972	+26.4%	Shares	Sole	2025-08-04
2025-03-31	$7,018,778	608,213	+10.6%	Shares	Sole	2025-05-01
2024-12-31	$4,655,857	549,688	-15.6%	Shares	Sole	2025-02-14
2024-09-30	$7,538,348	650,980	+23.0%	Shares	Sole	2024-10-29
2024-06-30	$6,235,919	529,365	0.0%	Shares	Sole	2024-08-06
2024-03-31	$6,278,268	529,365	+287.7%	Shares	Sole	2024-05-08
2021-09-30	$2,382,867	136,554	-66.4%	Shares	Sole	2021-10-28
2021-06-30	$9,732,839	406,212	-2.4%	Shares	Sole	2021-07-29
2021-03-31	$10,692,486	416,212	—	Shares	Sole	2021-04-29
No filing history on record for this holder in this stock.